Stay updated with breaking news from Software Module. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis,...
MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Boston Scientific Corporation has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track the...
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the FARAPULSE™ Pulsed...
The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment.
/PRNewswire/ -- Wolters Kluwer's ftwilliam.com, the market's leading provider of content and solutions for retirement plan service providers, is announcing its...